Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.280
+0.080 (2.50%)
At close: Nov 20, 2024, 4:00 PM
3.120
-0.160 (-4.88%)
After-hours: Nov 20, 2024, 7:59 PM EST
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $33.26 million as of November 21, 2024. Its market cap has increased by 43.25% in one year.
Market Cap
33.26M
Enterprise Value
18.09M
1-Year Change
43.25%
Ranking
Category
Stock Price
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $33.26M, a decrease of -61.86%. That is a compound annual growth rate of -7.10%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 33.67M |
| Moolec Science | 33.44M |
| Elevation Oncology | 32.52M |
| Iterum Therapeutics | 32.24M |
| Estrella Immunopharma | 32.21M |
| Curis | 31.83M |
| Precision Optics Corporation | 31.75M |
| BioVie | 30.95M |